The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration resistant prostate cancer: A randomized phase II trial (GROUQ-PCS 9).
 
Tamim Niazi
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Merck; Sanofi; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Rashmi Koul
No Relationships to Disclose
 
Isabelle Thibault
Honoraria - AstraZeneca Canada inc.
Consulting or Advisory Role - AstraZeneca Canada
 
Peter Chung
Honoraria - Knight Pharmaceuticals; Pfizer; Tersera; Tolmar
Consulting or Advisory Role - EMD Serono; Tersera; Tolmar
Research Funding - Abbvie
 
George Wakil
Consulting or Advisory Role - Abbvie; Astellas Pharma; Janssen; Knight Therapeutics/Biotoscana; Pfizer; Tersera; Tersera; Tolmar
Research Funding - Tolmar
 
Michael Lock
Stock and Other Ownership Interests - Myovant Sciences
Consulting or Advisory Role - Sanofi; Tersera
Speakers' Bureau - Abbvie; Eisai; Ferring
 
Guila Delouya
Employment - Yadtech (I)
Stock and Other Ownership Interests - Yadtech (I)
Honoraria - Abbvie; Astellas Pharma; Bayer; Elekta; Janssen Oncology; Sanofi; Tersera
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Knight Pharmaceuticals; Novartis; Pfizer; Sanofi; Tersera; tolmar
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Tolmar
 
Boris Bahoric
No Relationships to Disclose
 
Andrew Feifer
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Amgen; Astellas Pharma; Janssen Oncology
Speakers' Bureau - Janssen Oncology
Research Funding - Janssen-Ortho; Sanofi
Travel, Accommodations, Expenses - Janssen
 
Venkata Ramana Agnihotram
No Relationships to Disclose
 
Theodoros Tsakiridis
Honoraria - AstraZeneca; Sanofi
Research Funding - Astellas Pharma; Sanofi; Tolmar; Tolmar Canada
Travel, Accommodations, Expenses - Tolmar
 
Fabio Cury
Consulting or Advisory Role - Sanofi/Aventis
Speakers' Bureau - Varian Medical Systems
Research Funding - Boston Scientific (Inst); Tolmar (Inst)
Travel, Accommodations, Expenses - Varian Medical Systems
 
Rafika Dahmane
No Relationships to Disclose
 
Steven Tisseverasinghe
Honoraria - Abbvie; Bayer; Knight Therapeutics; Tolmar
Speakers' Bureau - Abbvie; Tolmar
Travel, Accommodations, Expenses - Tolmar; Tolmar
 
Nikhilesh Patil
Consulting or Advisory Role - TerSera Canada Inc
 
Scott Tyldesley
Honoraria - Bayer; Janssen Oncology; Pfizer; TerSera